HealthUS FDA approves GSK hepatitis B drug, offering an option after long-term treatment
The US Food and Drug Administration approved British drugmaker GSK’s hepatitis B drug Hibsago on Tuesday. It gives people with the liver infection a way to keep the virus under control after stopping treatment.
R
Reuters★★★☆☆2026-10-20 21:35Original
US FDA approves GSK hepatitis B drug, offering an option after long-term treatment
Health